Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study.
about
Irritability in ADHD: Associations with depression liabilityADHD Medication and Substance-Related Problems.Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder.Childhood hyperactivity and mood problems at mid-life: evidence from a prospective birth cohort.What are the benefits of methylphenidate as a treatment for children and adolescents with attention-deficit/hyperactivity disorder?Bright light therapy versus physical exercise to prevent co-morbid depression and obesity in adolescents and young adults with attention-deficit / hyperactivity disorder: study protocol for a randomized controlled trial.
P2860
Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Medication for Attention-Defic ...... ide Longitudinal Cohort Study.
@en
Medication for Attention-Defic ...... ide Longitudinal Cohort Study.
@nl
type
label
Medication for Attention-Defic ...... ide Longitudinal Cohort Study.
@en
Medication for Attention-Defic ...... ide Longitudinal Cohort Study.
@nl
prefLabel
Medication for Attention-Defic ...... ide Longitudinal Cohort Study.
@en
Medication for Attention-Defic ...... ide Longitudinal Cohort Study.
@nl
P2860
P50
P1476
Medication for Attention-Defic ...... ide Longitudinal Cohort Study.
@en
P2093
Patrick D Quinn
Zheng Chang
P2860
P304
P356
10.1016/J.BIOPSYCH.2016.02.018
P407
P577
2016-02-23T00:00:00Z